Will Johnson & Johnson Bid for the Rest of Elan Corporation PLC?

Published: Jul 09, 2012

Elan, which may be on the cusp of the biggest drug discovery ever unveiled by an Irish company, may be taken over by its partner Johnson & Johnson, if crucial trials work. Johnson & Johnson already owns 18.4 per cent of €6.9bn-valued Elan, following a complex deal which sees the US drug giant fund much of the research costs of its potential Alzheimer's wonder drug. Coming weeks will see key milestones for Elan and its partners as they await the results of trials before seeking to have the drug cleared by regulators.

Back to news